BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration

Reuters

Dec 10

BUZZ-Australia's <a href="https://laohu8.com/S/RHYN.AU">Rhythm Biosciences</a> gains on cancer test collaboration

** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week

** Stock hits highest since December 3

** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England

** ColoSTAT test is a blood-based test used to detect colorectal cancer

** YTD, RHY down ~6%

(Reporting by Aamir Sheik Khalid in Bengaluru)

((Aamir.SheikKhalid@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2590037422"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2590037422\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2590037422?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-10 11:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590037422","market":"us","top_or_hot":-1,"title":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> gains on cancer test collaboration</title></head><body><p>** <a href=\"https://laohu8.com/S/RHYBF\">Rhythm Biosciences</a> <span>RHY.AX</span> rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week</p><p>** Stock hits highest since December 3</p><p>** Medical diagnostics co <span>enters</span> collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England</p><p>** ColoSTAT test is a blood-based test used to detect colorectal cancer</p><p>** YTD, RHY down ~6%</p><p> (Reporting by Aamir Sheik Khalid in Bengaluru)</p><p> ((Aamir.SheikKhalid@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-10 11:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> gains on cancer test collaboration</title></head><body><p>** <a href=\"https://laohu8.com/S/RHYBF\">Rhythm Biosciences</a> <span>RHY.AX</span> rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week</p><p>** Stock hits highest since December 3</p><p>** Medical diagnostics co <span>enters</span> collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England</p><p>** ColoSTAT test is a blood-based test used to detect colorectal cancer</p><p>** YTD, RHY down ~6%</p><p> (Reporting by Aamir Sheik Khalid in Bengaluru)</p><p> ((Aamir.SheikKhalid@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7124","symbol_name":"保健护理服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL6N3XG05W:1","article_id":"2590037422","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590037422","pubTimestamp":1765336642,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week** Stock hits highest since December 3** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England** ColoSTAT test is a blood-based test used to detect colorectal cancer** YTD, RHY down ~6%  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7124":"保健护理服务","RHY.AU":"RHYTHM BIOSCIENCES LTD"},"translate_title":"BUZZ-澳大利亚Rhythm Biosciences在癌症测试合作中取得进展","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RHY.AU":0.9},"content_text":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week** Stock hits highest since December 3** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England** ColoSTAT test is a blood-based test used to detect colorectal cancer** YTD, RHY down ~6% (Reporting by Aamir Sheik Khalid in Bengaluru) ((Aamir.SheikKhalid@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}